Abstract
In this article, we examine the ethical implications of human transgenesis by considering the phenomenon in its larger evolutionary context. After clarifying the concept of transgenesis, we show that rather than unprecedented or unnatural, transgenesis is a common aspect of the evolutionary process that has likely affected all extant living animals, humans included. Additionally, we demonstrate that human transgenesis is technically feasible and that the moral barriers to it are mostly based on irrational fears premised on distorted and unrealistic views of “human nature”. Furthermore, we suggest that transgenically modifying persons might be morally preferable to relying blindly on the “natural lottery”, and that it is possible to do so in an ethical and responsible manner.
Similar content being viewed by others
Notes
Science fiction classics such as “The Fly”, “The Island of Dr. Moureau” and “Frankenstein” are probably the greatest source of transgenesis-related fear (cf. Brem and Anijar 2003; Karpowicz 2003). It is very unlikely that transgenesis will cause severe morphological changes (cf. Powell and Buchanan 2011: 64).
[N]aturae rationabilis individua substantia (Boecio 2005: 168).
Take, for instance, a hypothetical transgenic intervention that would cause the growth of an extra arm and a brain–machine interface integration that would allow the exact same change to occur by different means (cf. O'Doherty et al. 2011).
References
Aiuti, A., et al. (2002). Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science, 296, 2410–2413.
Akiba, T., et al. (1960). On the mechanism of the development of multiple-drug-resistant clones of Shigella. Japanese Journal of Microbiology, 4, 219–227.
Akinci, B., et al. (2010). Allergic reactions to human insulin: a review of current knowledge and treatment options. Endocrine, 37(1), 33–39.
Andam, C. P., Williams, D., & Gogarten, J. P. (2010). Natural taxonomy in light of horizontal gene transfer. Biology and Philosophy, 25, 589–602.
Belshaw, R., et al. (2004). Long-term reinfection of the human genome by endogenous retroviruses. Proceedings of the National Academy of Sciences of the USA, 101(14), 4894–4899.
Biotechnology Industry Organization—BIO. (2010). Healing, fueling, feeding: how biotechnology is enriching your life. http://www.valueofbiotech.com/sites/default/files/pdfs/ValueofBiotechFINAL.pdf. Accessed 26 April 2012.
Boecio. (2005). Escritos (Opuscala Sacra). São Paulo: Martins Fontes.
Bostrom, N., & Sandberg, A. (2009). The wisdom of nature: an evolutionary heuristic for human enhancement. In J. Savulescu & N. Bostrom (Eds.), Human enhancement (pp. 375–416). Oxford: Oxford University Press.
Brem, S. K., & Anijar, K. Z. (2003). The bioethics of fiction: the chimera in film and print. The American Journal of Bioethics, 3(3), 22–24.
Cavazzana-Calvo, M., et al. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 288, 669–672.
Check, E. (2005). Gene therapy put on hold as third child develops cancer. Nature, 433, 561.
Choi, C. (2006). Transgenic drug market heats up. The Scientist, Aug. 3rd.
Chou, H. H., et al. (2002). Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution. Proceedings of the National Academy of Sciences of the USA, 99, 11736–11741.
Cockrell, A. S., & Kafri, T. (2007). Gene delivery by lentivirus vectors. Molecular Biotechnology, 36, 184–204.
Cordaux, R., & Batzer, M. A. (2009). The impact of retrotransposons on human genome evolution. Nature Reviews Genetics, 10(10), 691–703.
Daniels, S. B., et al. (1990). Evidence for horizontal transmission of the P transposable element between Drosophila species. Genetics, 124(2), 339–355.
della Mirandola, G. P. (1994). Oratio de hominis dignitate. Pordenone: Edizioni Studio Tesi.
Doolittle, W. F., & Bapteste, E. (2007). Pattern pluralism and the tree of life hypothesis. Proceedings of the National Academy of Sciences of the USA, 104, 2043–2049.
EFSA, GMO Panel Working Group on Animal Feeding Trials. (2008). Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. Food and Chemical Toxicology, 46(Suppl 1), S2–S70.
Faulkner, G. J. (2011). Retrotransposons: mobile and mutagenic from conception to death. FEBS Letters, 585(11), 1589–1594.
Gilbert, C., et al. (2010). A role for host-parasite interactions in the horizontal transfer of transposons across phyla. Nature, 464(7293), 1347–1350.
Hohmann-Marriott, M. F., & Blankenship, R. E. (2011). Evolution of photosynthesis. Annual Review of Plant Biology, 62, 20.1–20.34.
Hug, K. (2008). Genetically modified organisms: do the benefits outweigh the risks? Medicina (Kaunas, Lithuania), 44(2), 87–99.
Karpowicz, P. (2003). In defense of stem cell chimeras: a response to “crossing species boundaries”. The American Journal of Bioethics, 3(3), 17–19.
Kawase, Y. (2011). Rescuing the failing heart by targeted gene transfer. Journal of the American College of Cardiology, 57, 1169–1180.
Keeling, P. J. (2009). Functional and ecological impacts of horizontal gene transfer in eukaryotes. Current Opinion in Genetics & Development, 19, 613–619.
Keeling, P. J., & Palmer, J. D. (2008). Horizontal gene transfer in eukaryotic evolution. Nature Reviews Genetics, 9(8), 605–618.
Konkel, M. K., & Batzer, M. A. (2010). A mobile threat to genome stability: the impact of non-LTR retrotransposons upon the human genome. Seminars in Cancer Biology, 20(4), 211–221.
Koonin, E. V., Makarova, K. S., & Aravind, L. (2001). Horizontal gene transfer in prokaryotes: quantification and classification. Annual Review of Microbiology, 55, 709–742.
Lander, E. S., et al. (2001). Initial sequencing and analysis of the human genome. Nature, 409, 860–921.
Levasseur, D. N., et al. (2003). Correction of a mouse model of sickle cell disease: lentiviral/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells. Blood, 102, 4312–4319.
Mostoslavsky, G., et al. (2006). Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proceedings of the National Academy of Sciences of the USA, 103, 16406–16411.
Nyberg, K., et al. (2004). Workshop on long-term follow-up of participants in human gene transfer research. Molecular Therapy, 10, 976–980.
O'Doherty, et al. (2011). Active tactile exploration using a brain–machine–brain interface. Nature, 479, 228–231.
Ott, M. G., et al. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nature Medicine, 12, 401–409.
Pinstrup-Andersen, P., & Schioler, E. (2000). Seeds of contention. Baltimore: Johns Hopkins University Press (International Food Policy Research Institute).
Powell, R., & Buchanan, A. (2011). Breaking evolution's chains: the promise of enhancement by design. In J. Savulescu, R. ter Meulen, & G. Kahane (Eds.), Enhancing human capacities (p. 64). Oxford: Blackwell.
Raven, P. H. (2010). Does the use of transgenic plants diminish or promote biodiversity? New Biotechnology, 27(5), 528–533.
Sagoff, M. (2005). Nature and human nature. In H. W. Baillie & T. K. Casey (Eds.), Is human nature obsolete? Genetics, bioengineering and the future of the human condition (pp. 67–98). Cambridge: The MIT Press.
Savulescu, J., Sandberg, A., & Kahane, G. (2011). Well-being and enhancement. In J. Savulescu, R. ter Meulen, & G. Kahane (Eds.), Enhancing human capacities (p. 7). Oxford: Blackwell.
Schaack, S., Gilbert, C., & Feschotte, C. (2010). Promiscuous DNA: horizontal transfer of transposable elements and why it matters for eukaryotic evolution. Trends in Ecology & Evolution, 25(9), 537–546.
Shrader-Frechette, K. (2005). Property rights and genetic engineering: developing nations at risk. Science and Engineering Ethics, 11(1), 137–149.
Thomas, C. M., & Nielsen, K. M. (2005). Mechanisms of, and barriers to, horizontal gene transfer between bacteria. Nature Reviews Microbiology, 3, 711–721.
Toole, J. J., et al. (1984). Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature, 312(5992), 342–347.
Uzogara, S. G. (2000). The impact of genetic modification of human foods in the 21st century: a review. Biotechnology Advances, 18(3), 179–206.
Venter, J. C., et al. (2001). The sequence of the human genome. Science, 291(5507), 1304–1351.
Wakeman, D. R., Dodiya, H. B., & Kordower, J. H. (2011). Cell transplantation and gene therapy in Parkinson's disease. The Mount Sinai Journal of Medicine, 78, 126–158.
Walgate, R. (1981). Pituitary slump. Nature, 290(5801), 6–7.
Wei, C. M., et al. (1981). Construction and isolation of a transmissible retrovirus containing the src gene of Harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 1. Journal of Virology, 39, 935–944.
Wiznerowicz, M., & Trono, D. (2005). Harnessing HIV for therapy, basic research and biotechnology. Trends in Biotechnology, 23, 42–47.
Wong, L. F., et al. (2006). Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications. Human Gene Therapy, 17, 1–9.
Woodard, K. L., & Underwood, A. (1997). Today the sheep, tomorrow the shepherd? Before scientists get there, ethicists want some hard questions asked and answered. Newsweek, 129(10), 60.
Wu, F. (2004). Explaining public resistance to genetically modified corn: an analysis of the distribution of benefits and risks. Risk Analysis, 24(3), 715–726.
Yoshiyama, M., et al. (2001). Possible horizontal transfer of a transposable element from host to parasitoid. Molecular Biology and Evolution, 18(10), 1952–1958.
Acknowledgements
Brunello Stancioli acknowledges the support of CAPES – as a beneficiary of one of its scholarships for post-doctoral studies abroad – for his work on this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
da Fonseca, F.G., Ribeiro, D.M., Carvalho, N.P. et al. Human Transgenesis: Definitions, Technical Possibilities and Moral Challenges. Philos. Technol. 25, 513–524 (2012). https://doi.org/10.1007/s13347-012-0074-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13347-012-0074-7